Study in reprogram of RBC paracrine signaling in type 2 diabetes leading cardiovascular injury

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: c14569aae90397b1c68e15eb268a4717ce86ec08
First added on: Oct 10, 2026